This Tata Group Company Is Planning To Appeal Against Government Department Order; Price Target After This News
Tata Group Share: The Income Tax Department imposed a fine on Tata Chemicals (NSE: TATACHEM) of Rs 103.63 Crore for violating rules related to the disallowance interest.
Tata Chemicals announced in a filing to the stock exchange, that the National Faceless Assessment Center (ITAD) had issued an order for the disallowance of interest under sections 36(1) and 270A(3). A fine of Rs. 103.63 crore was imposed.
What Was Tata Company Said?
Tata Group plans to appeal the order at the National Faceless Appeal Center. The company expects to receive a favourable decision from the appropriate authorities.
Tata Chemicals’ shares fell more than 8% earlier after the F&O Ban was lifted. On Friday, this share rose to Rs 1056.35.
Tata Sons Sold Shares
Tata Sons sold shares of Tata Consultancy Services worth Rs 9,300 Crore on the open market.
Tata Sons sold 234 lakh TCS shares or 0.65 percent of stock, on March 19, 2019. This sale is based on the closing price for TCS shares at Rs 3,977.55 on March 19.
Tata Sons began selling 2,34 crore shares under the bulk sale at a price floor of Rs 4,001.
This price is 3.65 % less than Monday’s closing price of Rs 4144.75 for the company shares.
Promoter and promoter-group entities owned 72.41 percent of TCS as of December 2023. Tata Sons held 72.38 percent of this stake.
About Tata Chemicals Ltd
Tata Chemicals Limited is an Indian company. It is a chemist who offers sustainable solutions.
The segments of the Company comprise Basic Chemistry Products and Specialty Products.
The primary Chemistry Products segment comprises inorganic chemical compounds, like salt, soda ash as well as sodium bicarbonate.
Inorganic chemicals are used in industries like glass (automotive architectural, automotive, and container) detergent food, pharma animal feed, industrial chemicals, and so on.
It runs manufacturing facilities across 4 continents: North America (United States of America), Europe (United Kingdom), Africa (Kenya) and Asia (India).
The Specialty Products segment includes three products that include specialty silica, prebiotics as well as Agri inputs.
Its silica-specific range is used in the rubber, food tire, and food industry. The prebiotics and formulations it offers are geared towards food as well as animal feed and pharmaceutical applications.
The company’s subsidiary is Rallis India Limited.
Fundamental Analysis of Tata Chemicals Ltd
Market Cap | ₹ 26,350 Cr. |
Current Price | ₹ 1,056.35 |
52-wk High | ₹ 1,350 |
52-wk Low | ₹ 922 |
Stock P/E | 15.2 |
Book Value | ₹ 840 |
Dividend | 1.69 % |
ROCE | 11.6 % |
ROE | 12.0 % |
Face Value | ₹ 10.0 |
P/B Value | 1.23 |
OPM | 20.5 % |
EPS | ₹ 71.7 |
Debt | ₹ 6,048 Cr. |
Debt to Equity | 0.28 |
Tata Chemicals Ltd Share Price Target 2024 To 2030
Year | 1st Target | 2nd Target |
2024 | ₹ 1400 | ₹ 1584 |
2025 | ₹ 1600 | ₹ 1684 |
2026 | ₹ 1742 | ₹ 1842 |
2027 | ₹ 1900 | ₹ 1945 |
2028 | ₹ 1955 | ₹ 1980 |
2029 | ₹ 2014 | ₹ 2215 |
2030 | ₹ 2315 | ₹ 2400 |
Tata Chemicals Ltd Shareholding Pattern
Promoters Holding | |
Dec 2022 | 37.98% |
Mar 2023 | 37.98% |
June 2023 | 37.98% |
Sept 2023 | 37.98% |
Dec 2023 | 37.98% |
FII Holding | |
Dec 2022 | 14.43% |
Mar 2023 | 14.59% |
June 2023 | 14.47% |
Sept 2023 | 14.16% |
Dec 2023 | 14.07% |
DII Holding | |
Dec 2022 | 18.97% |
Mar 2023 | 19.77% |
June 2023 | 19.91% |
Sept 2023 | 20.91% |
Dec 2023 | 20.44% |
Govt. Holding | |
Dec 2022 | 0.03% |
Mar 2023 | 0.03% |
June 2023 | 0.03% |
Sept 2023 | 0.03% |
Dec 2023 | 0.03% |
Public Holding | |
Dec 2022 | 28.60% |
Mar 2023 | 27.64% |
June 2023 | 27.63% |
Sept 2023 | 26.92% |
Dec 2023 | 27.49% |
Tata Chemicals Ltd Share: Last 5 Years’ Financial Condition
To better understand how the market is performing, let’s look at the outlook of this share in the previous years.
However, investors should be aware of the risks and the market conditions before making any investment decision.
Last 5 Years’ Sales:
2019 | ₹ 10,337 Cr |
2020 | ₹ 10,357 Cr |
2021 | ₹ 10,200 Cr |
2022 | ₹ 12,622 Cr |
2023 | ₹ 16,353 Cr |
Last 5 Years’ Net Profit:
2019 | ₹ 1,387 Cr |
2020 | ₹ 7,228 Cr |
2021 | ₹ 436 Cr |
2022 | ₹ 1,405 Cr |
2023 | ₹ 1,968 Cr |
Last 5 Years’ Debt-To-Equity Ratio:
2019 | 0.42 |
2020 | 0.42 |
2021 | 0.38 |
2022 | 0.37 |
2023 | 0.31 |
Last 10 Years’ Profit Growth:
10 Years: | 17% |
5 Years: | -1% |
3 Years: | -31 |
Current Year: | -17 |
Last 10 years’ Return on Equity (ROE):
10 Years: | 14% |
5 Years: | 16% |
3 Years: | 8% |
Last Year: | 12% |
Sales Growth Over 10 Years:
10 Years: | 1% |
5 Years: | 10% |
3 Years: | 17% |
Current Year: | 3% |
Conclusion
This article is a complete guide about Tata Chemicals Ltd Share.
These information and forecasts are based on our analysis, research, company fundamentals and history, experiences, and various technical analyses.
Also, We have talked in detail about the share’s future prospects and growth potential.
Hopefully, these informations will help you in your further investment.
If you are new to our website and want to get all the latest updates related to the stock market, join us on Telegram Group.
If you have any further queries, please comment below. We will be happy to answer all your questions.
If you like this information, share the article with as many people as possible.
Disclaimer: Dear readers, we’d like to inform you that we are not authorized by SEBI (Securities and Exchange Board of India). The information on this site is only for informational and educational purposes and shouldn’t be considered financial advice or stock recommendations. Also, the share price predictions are completely for reference purposes. The price predictions will only be valid when there are positive signs on the market. Any uncertainty about the company’s future or the current state of the market will not be considered in this study. We are not responsible for any financial loss you might incur through the information on this site. We are here to provide timely updates about the stock market and financial products to help you make better investment choices. Do your own research before any investment.